Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma (Q26827104)

main subject

squamous cell carcinoma

1 reference

1

Patcharee Ritprajak

1 reference

2

Miyuki Azuma

1 reference

language of work or name

1 reference

March 2015

1 reference

1 reference

51

1 reference

issue

3

1 reference

page(s)

221-8

1 reference

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Epithelial-mesenchymal transitions: twist in development and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Checkpoint blockade in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

The emerging role of CTLA-4 as an immune attenuator

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Programmed death ligand-1 expression in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

The blockade of immune checkpoints in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Advances in targeting cell surface signalling molecules for immune modulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Inhibitory B7-family molecules in the tumour microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Tumor Immunotherapy Directed at PD-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Nivolumab plus ipilimumab in advanced melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

TLR4 signaling induces B7-H1 expression through MAPK pathways in bladder cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Expression and regulation of human CD275 on endothelial cells in healthy and inflamed mucosal tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Immune suppression in head and neck cancers: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Immunoregulatory molecule B7-H1 (CD274) contributes to skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Identification of a subset of human non-small cell lung cancer patients with high PI3Kβ and low PTEN expression, more prevalent in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Expression of B7-H1 in inflammatory renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

PTEN deficiency contributes to the development and progression of head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Molecular changes in the multistage pathogenesis of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Loss of B7-H1 expression by recipient parenchymal cells leads to expansion of infiltrating donor CD8+ T cells and persistence of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Expression of programmed death 1 ligands by murine T cells and APC

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

Antibodies to watch in 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021

PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ORALONCOLOGY.2014.11.014

7 January 2021